Yield10 Bioscience, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 3.27 million compared to USD 3.3 million a year ago. Basic loss per share from continuing operations was USD 0.27 compared to USD 0.67 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2285 USD | +3.02% | -12.45% | -4.51% |
Apr. 01 | Transcript : Yield10 Bioscience, Inc., Q4 2023 Earnings Call, Apr 01, 2024 | |
Apr. 01 | Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.51% | 3.42M | |
+1.85% | 42.75B | |
+47.70% | 41.61B | |
+12.43% | 41.34B | |
-8.83% | 26.59B | |
+7.52% | 25.49B | |
-23.07% | 18.12B | |
+30.55% | 12.24B | |
-2.03% | 11.76B | |
+8.19% | 11B |
- Stock Market
- Equities
- YTEN Stock
- News Yield10 Bioscience, Inc.
- Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023